REQUEST A DEMO
Total
USD $0.00
Search more companies

Merlin Pharma Private Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Merlin Pharma Private Limited Profile Updated: April 02, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Merlin Pharma Private Limited is an enterprise based in India. Its main office is in Mumbai. It operates in the Pharmaceutical and Medicine Manufacturing industry. It was first established on August 11, 1988. It currently has a total number of 7 (2024) employees. In its most recent financial highlights, the company reported a net sales revenue increase of 23.96% in 2024. Its’ total assets recorded a growth of 17.9%. The net profit margin of Merlin Pharma Private Limited increased by 0.4% in 2024.

Legal Address
402, Kalpataru Plaza, Chincholi Bunder Rd Malad (W)
Mumbai; Maharashtra; Postal Code: 400064

Contact Details: Purchase the Merlin Pharma Private Limited report to view the information.

Basic Information
Total Employees:
Purchase the Merlin Pharma Private Limited report to view the information.
Registered Capital:
Purchase the Merlin Pharma Private Limited report to view the information.
Financial Auditors:
Purchase the Merlin Pharma Private Limited report to view the information.
Incorporation Date:
August 11, 1988
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Professional Director
Company Performance
Financial values in the chart are available after Merlin Pharma Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
23.96%
Total Operating Revenue
23.92%
Operating Profit
42.55%
EBITDA
26.41%
Net Profit/Loss for the Period
52.08%
Total Assets
17.9%
Total Equity
68.16%
Operating Profit Margin
0.36%
Net Profit Margin
0.4%
Return on Equity (ROE)
-0.87%
Debt / Equity
5.07%
Quick Ratio
0.29%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?